144

REFERENCES Reference to a journal publication: [1] J. van der Geer, J.A.J. Hanraads, R.A. Lupton,

The art of writing a scientific article, J. Sci. Commun.

163 (2010) 51–59.

Reference to a book: [2] W. Strunk Jr., E.B. White, The Elements of Style, fourth ed.,

Longman, New York, 2000.

Reference to a chapter in an edited book: [3] G.R. Mettam, L.B. Adams, How to

prepare an electronic version of your article, in: B.S. Jones, R.Z. Smith (Eds.),

Introduction to the Electronic Age, E-Publishing Inc., New York, 2009, pp. 281–304.

[1] Hasumati Rahalkar, Historical overview of pharmaceutical Industry and Drug

regulatory affairs, Pharmaceutical Regulatory Affairs. S11 (2012) 1-11.

doi:10.4172/2167-7689.S11-002

[2] J.R. Sharp, The problems of process Validation, Pharma journal. 1 (1986) 43-

5.

[3] S. Chow, Pharmaceutical Validation and Process Controls in Drug

Development, Drug Information Journal. 31 (1997) 1195-201.

[4] Elsie Jatto et al, Tropical Journal of Pharmaceutical Research. 1 (2002) 115-

122.

[5] L. Suntornsuk, Recent advances of capillary electrophoresis in pharmaceutical

analysis, Analytical and Bioanalytical Chemistry. 398(2010) 29-52.

[6] A. Pluym, W.V. Ael,M. De Smet, Capillary electrophoresis in

chemical/pharmaceutical quality control,Trends in Analytical Chemistry.

11(1992) 27-32.

[7] M.H. Simonian, J.A. Smith, Spectrophotometric and colorimetric

determination of protein concentration, in: Current Protocols in Molecular

Biology, Wiley Interscience, New York, 2006, Unit 10.1A, pp. 519.

[8] F.S. Rojas, C.B. Ojeda, Recent development in derivative ultraviolet/visible

absorption spectrophotometry: A review, Analytica Chimica Acta. 635 (2009)

22-44.

[9] C.B. Ojeda, F.S. Rojas, Recent developments in derivative ultraviolet/visible

absorption spectrophotometry, Analytica Chimica Acta. 518 (2004) 1-24.

145

[10] M.D.P.T. Sotomayor, I.L.T. Dias, M.R.V. Lanza, A.B. Moreira, L.T. Kubota,

Application and advances in the luminescence spectroscopy in pharmaceutical

analyses, Quimica Nova, 31(2008) 1755-1774.

[11] A.A. Eiroa, G. de-Armas, J.M. Estela, V. Cerda, Critical approach to

synchronous spectrofluorimetry, Trends in Analytical Chemistry. 29(2010)

885-901.

[12] A.L. Santos, R.M. Takeuchi, N.R. Stradiotto, Electrochemical,

spectrophotometric and liquid chromatographic approaches for analysis of

tropical disease drugs, Current Pharmaceutical Analysis. 5(2009) 69-88.

[13] J.L. Veuthey, Capillary electrophoresis in pharmaceutical and biomedical

analysis, Analytical and Bioanalytical Chemistry. 381(2005)93-95.

[14] James. M. Miller., Chromatography Concepts and Contrasts, second ed.,

John Wiley & Sons, New York, 2005.

[15] J Cazes, R.P.W. Scott, Chromatography Theory, New York Dekker, John

Wiley & Sons, New York, 2002.

[16] J. Sherma, Modern thin layer chromatography, Journal of AOAC

International. 91(2008) 1142-1144.

[17] K. Ferenczi-Fodor, Z. Vegh, A. Nagy-Turak, B. Renger, M. Zeller, Validation

and quality assurance of planar chromatographic procedures in pharmaceutical

analysis, Journal of AOAC International. 84 (2001) 1265-1276.

[18] R. Martino, M. Malet-Martino, V. Gilard, S. Balayssac, Counterfeit drugs:

analytical techniques for their identification, Analytical and Bioanalytical

Chemistry, 398 (2010) 77–92.

[19] B. Dejaegher, Y.V. Heyden, HILIC methods in pharmaceutical analysis,

Journal of Separation Science. 33 (2010) 698-715.

[20] H. Willard, L. Merritt, A. Dean, Instrumental Methods of Analysis, second

ed., CBS publishers and distributors, Delhi, 1986.

[21] M. Martin, G. Guiochon, Effects of high pressures in liquid chromatography,

Journal of Chromatography A. 7(2005) 16-38.

146

[22] Y. Liu, M. Lee, Ultrahigh pressure liquid chromatography using elevated

temperature,Journal of Chromatography. 1104 (2006) 198–202.

[23] S.L. Abidi, High performance liquid chromatography of phosphatidic acids

and related polar lipids, Journal of Chromatography. 587 (1991) 193-203.

[24] M.T.W. Hearn, Ion pair chromatography on normal and reversed phase

systems, Advanced Chromatography. 18 (1980) 59–100.

[25] L.S Ettre, A. Zlatkis, 75 Years of Chromatography a Historical Dialogue, in:

Journal of Chromatography Library (Eds.), Elsevier., Amsterdam, 1979, pp.

155.

[26] T. Schaefer Kuchler, J. Simat, H. Steinhart, Migration of lubricants from food

packagings, Journalof ChromatographyA.1017 (2003) 107–116.

[27] R. K. Iler, Chemistry of Silica,Wiley Interscience, New York, 1979.

[28] G. V. Lisichkin, Chemistry of Modified Surface Compounds, Phys Math Lit,

Moscow, 2003.

[29] K. K. Unger, Porous Silica: Its Properties and Use as Support in Column

Liquid Chromatography, in: Journal of Chromatography Library (Eds.),

Elsevier, Amsterdam, 1979.

[30] G. Watson, Pharmaceutical analysis: A text book for pharmacy students and

pharmaceutical chemists, Churchill, Livingstone, 1999, pp. 240-241.

[31] A. Skoog, M. Donald, Fundamentals of analytical chemistry,Thomson brooks,

2004, PP. 974-975.

[32] J.H. Knox, J.N. Done, A.F. Fell,HighPerformance Liquid Chromatography,

Edinburgh University Press, Edinburgh,1978.

[33] C.F. Simpson, Practical High Performance Liquid Chromatography, Heyden

and Son, London, 1976.

[34] E. Pungor, A Practical Guide to Instrumental Analysis, Boca Raton, CRC

Press,1995.

[35] A.C. Moffat, M.D. Osselton, B. Widdop, Clarkes Analysis of Drugs and

Poisons, Pharmaceutical Press, London,2004.

[36] U.S. Department of Health and Human Services, Food and Drug

Administration, Center for Drug Evaluation and Research, Center for

147

Veterinary Medicine, Guidance for Industry, Bioanalytical Method Validation,

2001.

[37] Validation of chromatographic methods, Reviewer Guidance, U.S.

Department of Health and Human Services, Food and Drug Administration,

Center for Drug Evaluation and Research,1994.

[38] Analytical Procedures and Methods Validation, U.S. Department of Health

and Human Services, Food and Drug Administration, 2000.

[39] G.C. Hokanson, A life cycle approach to the validation of analytical methods

during pharmaceutical product development,in: part I- The initial validation

process, Pharm Tech, 1994, pp. 118‐30.

[40] G.C.Hokanson,, A life cycle approach to the validation of analytical methods

during pharmaceutical product development, in: part II- Changes and the need

for additional validation, Pharm Tech, 1994, pp.92‐100.

[41] International Conference on Harmonization of Technical Requirements for

Registration of Pharmaceuticals for Human Use, Validation of Analytical

Procedures: Text and Methodology, Q2 (R1), 2005.

[42] M.A. Korany, H. Mahgoub, T.F. Ossama, M.M. Hadir, Application of

artificial neural networks for response surface modelling in HPLC method

development, Journal of Advanced Research. 3 (2012) 53–63.

[43] A. Ferrarini, A.L. Huidobro, F. Pellati, C. Barbas, Development and validation

of a HPLC method for the determination of sertraline and three non-chiral

related impurities ,Journal of Pharmaceutical Biomedical Analysis. 53 (2010)

122–129.

[44] M.E. Swartz, M.D.Jone, P.Fowler, M.A. Andrew; Automated HPLC method

development and transfer, Lc Gc North America. 75 (2002) 49-50.

[45] L.R. Synder, J.J. Kirkland, J.L. X. Glajach, In Practical HPLC Methods

Development, John Wiley., New York, 1997, pp. 643-712.

[46] M. Swartz, M.B. Murphy, New Fronties in Chromatography, Am Lab, 2005,

pp. 22-27.

[47] Z. Debebe, S. Nekhai, M. Ashenafi, B.L. David, D.S. Kalinowski, R.G Victor,

W.M. Byrnes, D.R. Richardson, P.K. Karla, Development of a sensitive HPLC

method to measure in vitropermeability of E- and Z-isomeric forms of

148

thiosemicarbazones in Caco-2 monolayers, Journal of Chromatography B. 906

(2012) 25–32.

[48] Fu. Qiang, M. Shou, D. Chien, R. Markovich, A.M. Rustum, Development

and validation of a stability-indicating RPHPLC method for assay of

betamethasone and estimation of its related compounds, Journal of

Pharmaceutical Biomedical Analysis. 51 (2010) 617–625.

[49] A.T. Nguyen, T. Aerts, D.W. Dam, P.P.D. Deyn, Biogenic amines and their

metabolites in mouse brain tissue: Development, optimization and validation

of an analytical HPLC method, Journal of Chromatography B. 878. (2010)

3003–3014.

[50] S. Deng, J.W. Brett, C.J. Jensen, S. Basar, J. Westendorf, Development and

validation of an RP-HPLC method for the analysis of anthraquinones in noni

fruits and leaves, Food Chemistry. 116 (2009) 505–508.

[51] S.K. Sinha, P.K. Shrivastava, Development and validation of a HPLC method

for the simultaneous estimation of amlodipin and telmisartan in

pharmaceutical dosage form, Asia Pacific Journal of Molecular Biology and

Biotechnology. 1 (2012) 312–315.

[52] E.L. Inman, J.K. Frischmann, P.J. Jimenez, G.D. Winkle, M.L. Persinger, B.

S. Rutherford, General method validation guidelines for pharmaceutical

samples, Journal of Chromatographic Science. 25 (1987) 252−256.

[53] V.P. Shah, K.K. Midha, S. Dighe, I.J. McGilverray, J.P. Skey, A. Yacobi, T.

Layoff, C.T. Viswanathan, C.E. Cook, R.D. McDowall, K. A. Pittman, S.

Spector, Quantitative tests of the moiety in bulk active pharmaceutical

ingredient, Pharma Research. 9 (1992) 588−592.

[54] J. Mark Green, A practical guide to analytical method validation, Analytial

Chemistry. 68 (1996) 305A−309A.

[55] D.H. Shewiyo, E. Kaale, P.G. Risha, B. Dejaegher, J.S. Verbeke, Y.V.

Heyden, HPTLC methods to assay active ingredients in pharmaceutical

formulations: A review of the method development and validation steps,

Analytical Journal of Pharmaceutical and Biomedical Analysis. 66 (2012) 11–

23.

[56] M.D. Rockville, General Tests, Chromatography System Suitability, in:

United States Pharmacopeial Convention (USP)., Chapter 621, USP 31, 2009.

149

[57] ISO/IEC, Guide 99 International vocabulary of metrology – Basic and general

concepts and associated terms (VIM), First edition, Geneva-International

Organization for Standardization, 2007.

[58] A.R.C. Hill, S.L. Reynolds, Guidelines for Inhouse validation of analytical

methods for pesticide residues in food and animal feeds, Analyst. 124 (1999)

953-958.

[59] F. Elbarbry, K. Wilby, J. Alcorn, Validation of a HPLC method for the

determination of p-nitrophenol hydroxylase activity in rat hepatic microsomes,

Journal of Chromatography B. 834 (2006) 199–203.

[60] U.S. Pharmacopoeia, Validation of Compendial Methods, USP-26-NF21,

2003.

[61] S. Chandran, R.S.P. Singh, Comparision of various international guidelines for

analytical method validation, Die Pharmazie: An international journal of

pharmaceutical sciences. 62(2007) 4-14.

[62] J.M. Green, A practical gide to analytical method validation, Analtical

Chemistry. 68 (1996) 305A-309A.

[63] D.M. Bliesner, Validating Chromatographic Methods: A Practical Guide. John

Wiley & Sons Inc, Hoboken, New Jersey, 2006.

[64] L.R. Snyder, J. Joseph, Kirkland, L. Joseph, Practical HPLC Method

Development, second Edition, John Wiley & Sons Inc., Hoboken, New Jersey,

2006.

[65] US FDA, General Principles of Validation, Center for Drug Evaluation and

Research, Rockville, MD, 1987.

[66] G. Tranfo, P. Enrico, S. Renata, P. Daniela, Validation of an HPLC/MS/MS

method with isotopic dilution for quantitative determination of trans, trans-

muconic acid in urine samples of workers exposed to low benzene

concentrations, Journal of Chromatography B. 867 (2008) 26–30.

[67] US FDA, Guidelines for Submitting Samples and Analytical Data for Methods

Validation, Center for Drugs and Biologies Department, 2014.

[68] O. Gonzalez, G. Iriarte, N. Ferreiros, M.I. Maguregui, R.M. Alonso, R.M.

Jimenez, Optimization and validation of a SPE-HPLCPDA- fluorescence

method for the simultaneous determination of drugs used in combined

150

cardiovascular therapy in human plasma, Journal of Pharmaceutical

Biomedical. 50 (2009) 630–639.

[69] ICH Q2 (R1), Validation of Analytical Procedures Text and Methodology,

International Conference on Harmonization, IFPMA, Geneva, 2005.

[70] M.T.T. Trani, M.P. Katherine, C. Marlyn, Matrix-specific method validation

for quantitative analysis of vitamin C in diverse foods, Journal of Food

Compost Analysi. 26 (2012) 12–25.

[71] Y.S. Hernandez, L.B. Sanchez, M.M.G. Bedia, T.G. Luis, Determination of

parthenin in Parthenium hysterophorus by means of HPLC-UV: Method

development and validation, Phytochem Letter. 4 (2011) 134–137.

[72] J.M. Green, A practical guide to analytical method validation, Analytical

Chemistry. 68 (1996) 305A-309A.

[73] D.M. Bliesner, Validating Chromatographic Methods, A Practical Guide, John

Wiley & Sons Inc., Hoboken, New Jersey, 2006.

[74] M. Thompson, S.L.R. Ellison, R. Wood, Guidelines for Single Laboratory,

Validation of Methods of Analysis, Pure Applied Chemistry. 74 (2002) 835–

855.

[75] L.R. Snyder, J. Joseph, Kirkland, L. Joseph, Practical HPLC Method

Development, second Edition, John Wiley & Sons Inc, Hoboken, New Jersey,

2006.

[76] Analytical Methods Committee, Analytical Division, The Royal Society of

Chemistry Analyst. 119 (1994) 2363-2366.

[77] M. Thompson, Basic chemometric techniques in atomic spectroscopy,

Analalytical Proc. 27 (1990) 142-144.

[78] P. Araujo, Key aspects of analytical method validation and linearity

evaluation, Journal of Chromatography B. 877 (2009) 2224–2234.

[79] A. Martnez, J. Riu, F.X. Rius, Multiple analytical method comparision using

maximum livelihood principal component analysis and linear regression with

errors in both axes, Analytica Chemica acta. 446 (2001) 147-158.

[80] V.C. Scheilla, De Souza, G. Roberto, A process to assess linearity by ordinary

least squares method, Journal of Analytica Chimica Acta. 552 (2005) 25-35.

[81] AOAC Peer Verified Methods Program, Manual on policies and procedures,

Arlington, VA 1993.

151

[82] L.A. Pasteelnick, Analytical methods validation. In: Nash RA, Berry IR,

Pharmaceutical process validation, second edition, Marcel Dekker Inc, New

York, 1993, pp. 411–428.

[83] Thompson, M.; Ellison, S.L.R.; and Wood, R.; Pure Appl Chem, 74, 2002,

835–855.

[84] Huang Liusheng, Lizak Patricia, Aweeka Francesca, Long Boyle Janel,

Dvorak, C. Christophe, Long-Boyle Janel and Dvorak Christopher C,

Simultaneous determination of fludarabine and clofarabine in human plasma

by LC-MS/MS, Journal of Chromatography B: Analytical Technologies in the

Biomedical and Life Sciences. 960 (2014) 194-199.

[85] R. Ficarra, M.L. Calabro, S. Tommasini, A. Villari, S. Melardi, S. Coppolino,

M. Semreen, P. Ficarra, Determination of fludarabine in a pharmaceutical

formulation by LC, Journal of pharmaceutical and biomedical analysis.

21(1999) 1077-81.

[86] Li. Liwei, Chen. Bangyin, Zhang, Hanping, Determination of fludarabine

phosphate by HPLC, Zhongguo Yaoshi. 8 (2005) 482-483.

[87] Misztal, Genowefa, B. Paw, Determination of fludarabine phosphate in human

plasma using reversed phase high-performance liquid chromatography,

Pharmazie. 51 (1996) 733-734.

[88] A.M. El Didamony, E.A.H Erfan, Cerimetric determination of four

antihypertensive drugs in pharmaceutical preparations, Journal of the Chilean

Chemical Society. 56 (2011) 875-880.

[89] Nagasuri. Ravindra, Singhvi. Indrajeet, Pillai. Sujit, Estimation of diltiazem

hydrochloride from tablet formulation using spectrophotometric methods,

Research Journal of Pharmacy and Technology. 2 (2009) 730-731.

[90] Vidya.V. Gawande, A.V. Chandewar, Development and validation of

spectroscopic method for estimation of diltiazem hydrochloride in solid

dosage form, Journal of Pharmacy Research. 3 (2010) 3032-3033.

[91] C. Bodson, E. Rozet, E. Ziemons, B. Evrard, Ph. Hubert, L. Delattre,

Validation of manufacturing process of DiltiazemHCl tablets by NIR

spectrophotometry, Journal of Pharmaceutical and Biomedical Analysis. 45

(2007) 356-361.

152

[92] H.H. Hassanein, S. Mostafa, M.S. Gomaa, Spectrophotometric methods for

determination of benazepril hydrochloride and diltiazem hydrochloride,

Egyptian Journal of Biomedical Sciences. 17 (2005) 268-282.

[93] N. Rahman, S.N. Hejaz Azmi, Extractive spectrophotometric methods for

determination of diltiazemHCl in pharmaceutical formulations using

bromothymol blue, bromophenol blue and bromocresol green, Journal of

Pharmaceutical and Biomedical Analysis. 24 (2000) 33-41.

[94] M. Ayad Magda,; Shalaby Abdall, E. Abdellatef Hisham, M. Hosny Mervat,

New colorimetric methods for the determination of trazodoneHCl, famotidine,

and diltiazemHCl in their pharmaceutical dosage forms, Analytical and

Bioanalytical Chemistry. 376 (2003) 710-714.

[95] M. Lacroix Pauline, Beaulieu Normand, D. Cyr Terry, Lovering, G. Edward,

High-performance liquid chromatography method for assay of diltiazem

hydrochloride and its related compounds in bulk drug and finished tablets,

Journal of Pharmaceutical Sciences. 78 (1989) 243-6.

[96] Galina. Holloway, Heather. Rowe Joyce, Samir. Wahab, A stability-indicating

HPLC procedure for determination of diltiazem hydrochloride in

extemporaneously compounded oral liquids, Pharmaceutical Technology

Europe, Pharmaceutical Technology Europe. 20 (2008) 38-40, 42-45.

[97] Riddhi. Dave. Maheshbhai, RP-HPLC method development and validation of

etoposide, Journal of Pharmacy Research. 5 (2012) 3618.

[98] YE Hong yang, Simultaneous determination of the content and the related

substances of etoposide implants by HPLC, Anhui Medical and

Pharmaceutical Journal. 2009-07.

DOI: http://en.cnki.com.cn/Article_en/CJFDTotal-AHYY200907016.htm

[99] D. Chow, Stability-indicating high-performance liquid chromatography of

etoposide at various ph conditions using a reversed-phase octyl column,

Journal of Chromatography A. 396 (1987) 217–223.

[100] K Manouilov. Konstantine, A Knight Jennifer, M Davis. Estella, B. Hoie.

Eric, Assay for etoposide in human serum using solid-phase extraction and

high-performance liquid chromatography with fluorescence detection, Journal

of Chromatography B: Biomedical Sciences and Application. 1-2 (2003) 321-

4.

153

[101] M. Munawar. Hayat, Muhammad. Ashraf, Nisar Ur Rehman, Faiz Ul Hassan.

Nasim, Irshad. Ahmad, Jameel. Rahman, Muhammad Saleem, M. Malik

Zubairj, HPLC determination of etoposide in injectable dosage forms, Journal

of the Chilean Chemical Society. 56 (2011) 881-883.

[102] J.J.M. Holthuis, Plasma assay for the antineoplastic agent VP 16-213

(etoposide) using high-performance liquid chromatography with

electrochemical detection, Journal of Pharmaceutical and Biomedical

Analysis. 1 (1983) 89–97.

[103] E. Chamani, Spectroscopic detection of etoposide binding to chromatin

components: The role of histone proteins, Spectrochim Acta A Mol Biomol

Spectroscopy. 133 (2014) 292-9.

[104] Radi. Abd Elgawad, Voltammetric and ultraviolet–visible spectroscopic

studies on the interaction of etoposide with deoxyribonucleic acid,

Electrochemica Acta. 113 (2013) 164-169.

[105] Tavares de Sousa, Rodrigues da Silva, Camila, Pianetti. Gisele, Antonio.

Gerson, Solano, A Gabriela Reis, Spectrophotometric determination of

etoposide from polymeric implant and application in the study of in vitro

release, Profile, Revista Brasileira de Farmacia. 94 (2013) 295-301.

[106] Raza Abida, Aman Akhtar, Bashir Shumaila, Ahmad Bashir, Irfan Javaid, J.

Dev. Mehta, Hardyal S. Gill, Khan. Abad. Alam, Mehboob, Schatzlein, G.

Andreas, RAPID and sensitive liquid chromatographic method for

determination of etoposide in plasma and biological samples, Journal of

Liquid Chromatography & Related Technologies. 36 (2013) 2796-2813.

[107] Solano, Ana Gabriela Reis, Rodrigues da Silva, Gisele Fialho, Silvia Ligorio,

Cunha, Armando da Silva Jr, Pianetti, Gerson Antonio, Development and

validation of a High Performance Liquid Chromatographic method for

determination of etoposide in biodegradable polymeric implants, Quimica

Nova. 35 (2012) 1239-1243.

[108] Ashraf Muhammad, Hayat Muhammad Munawar, Nasim, Faiz Ul Hassan,

Ahmad Irshad, Saleem Muhammad, Rahman Jameel, Development and

validation of RP-HPLC method for the simultaneous determination of

etoposide and cisplatin and its application in quality control of injectable

dosage forms, Journal of the Chemical Society of Pakistan. 34 (2012) 321-

325.

154

[109] M. Munawar. Hayat, Ashraf, Muhammad, Nisar Ur Rehman, Nasim, Faiz

UlHassan, Ahmad. Irshad, Rahman Jameel, Saleem, Muhammad, M.Malik,

Zubair, HPLC determination of etoposide in injectable dosage forms, Journal

of the Chilean Chemical Society. 56 (2011) 881-883.

[110] Cao Yunli, Du Xiaoli, Zhu Zhu, Fu Qiang, HPLC assay for determination of

etoposide in human plasma, Zhongguo Yaoxue Zazhi. 46 (2011) 857-859.

[111] Wang Peng san, Zhou Hao bing, Wu Rong lian, Ye Hong yang, Wang Qing

shun, Wang Shi liang, HPLC determination of etoposide sustained release

implant and its related substances, Zhongguo Xinyao Zazhi, 12 (2003) 355-

357.

[112] Kato Yasuhiro, Mawatari Hideo, Nishimura Shin Ichiro, Sakura Nobuo, Ueda

Kazuhiro, Determination of etoposide serum concentrations in small pediatric

samples by an improved method of reversedphase high-performance liquid

chromatography, Acta Medica Okayama. 57 (2003) 21-24.

[113] Chu Chengding, Xu Jianjian, Zhang Haiyan, Xie Zheng Ye, Hongyang,

Determination of etoposide (VP-16) concentration in plasma after

subcutaneously implanted by reversed-phase high performance liquid

chromatography, Sepu. 21 (2003) 56-59.

[114] Demperio, L. Vincent, Determination of etoposide phosphate intermediates by

gradient liquid chromatography using post column derivatization with

cuprammonium hydroxide, Journal of Chromatography A. 952 (2002) 283-

287.

[115] Pang Shaokun, Zheng Naiyu, A Felix Carolyn, Scavuzzo Jennifer, Boston

Ray, A. Blair Ian, Simultaneous determination of etoposide and its catechol

metabolite in the plasma of pediatric patients by liquid

chromatography/tandem mass spectrometry, Journal of Mass Spectrometry. 36

(2011) 771-781.

[116] F.H. Shirazi, G. Bahrami, D.J. Stewart, E. Tomiak, F. Delorme, D. Noel, R.

Goel, A rapid reversed phase high performance liquid chromatographic

method for determination of etoposide (VP-16) in human plasma, Journal of

Pharmaceutical and Biomedical Analysis. 25 (2001) 353-356.

[117] R. Zhou, M. Frostvik Stolt, E. Liliemark, Determination of etoposide in

human plasma and leukemic cells by high-performance liquid chromatography

155

with electrochemical detection, Journal of Chromatography B: Biomedical

Sciences and Applications. 757 (2001) 135-141.

[118] Peng, Xingsheng, Determination of etoposide phosphate and related substance

by HPLC, Zhongguo Yaoxue Zazhi. 34 (1999) 485-487.

[119] Xie Jianxun, Li Yuzhen, Wang, Pei, Determination of etoposide (VP16) in

human serum by high-performance liquid chromatography, Sepu. 16 (1998)

74-75.

[120] Beaupin, M. Cecile, Darmanaden, Roland, Quality control in a centralized

reconstitution unit of cytotoxic agents: Determination of etoposide using

highperformance thin layer chromatography, Journal of Oncology Pharmacy.

2 (1996) 35-41.

[121] J. Perez Urizar, Y.F Pico, B. Navarro Gonzalez, F.J. Flores Murrieta, G.

Castaneda Hernandez, A new rapid and economical high performance liquid

chromatographic assay with electrochemical detection for the determination of

etoposide (VP-16) in human plasma samples, Journal of Liquid

Chromatography & Related Technologies. 19 (1996) 939-47.

[122] Zhu Guangwen, Liu Huichen, Li Xinfang, Shen Lixia, Guo Qiaolan, Gao

Huiqin, Determination of etoposide in human serum by high performance

liquid chromatography, Sepu. 12 (1994) 206-7.

[123] A. Fleming Ronald, F. Stewart Clinton, High performance liquid

chromatographic determination of etoposide in plasma, Journal of Liquid

Chromatography. 14 (1991) 1275-83.

[124] B.J. Floor, A.E. Klein, N. Muhammad, D. Ross, Stability indicating liquid

chromatographic determination of etoposide and benzyl alcohol in injectable

formulations, Journal of Pharmaceutical Sciences. 74 (1985) 197-200.

[125] M. Rideout James, C. Ayres David, C.K Lim, T.J. Peters, Determination of

etoposide (VP16-213) and teniposide (VM-26) in serum by high performance

liquid chromatography with electrochemical detection, Journal of

Pharmaceutical and Biomedical Analysis. 2 (1984) 125-8.

[126] J. LittlewoodT, A.L. Hutchings, D.P. Bentley, B.P. Spragg, High performance

liquid chromatographic determination of etoposide in plasma using

electrochemical detection, Journal of Chromatography, Journal of

Chromatography, Biomedical Applications. 336 (1984) 434-7.

156

[127] H.H. Ploegmakers, P.A. Moritz, P.J. Toll, W.J. van Oort, Computerized cyclic

voltammetric detection after HPLC of the antineoplastic agents etoposide,

teniposide, adriamycin and its metabolite adriamycinol in urine samples, The

Journal of automatic chemistry. 11 (1989) 106-12.

[128] R. Zhou, M. Frostvik Stolt, E. Lilie mark, Determination of etoposide in

human plasma and leukemic cells by HPLC with electro chemical detection,

Journal of chromatography B, Biomedical sciences and applications. 757

(2001) 135-41.

[129] C. Chen, Highly sensitive liquid chromatography-electrospray mass

spectrometry (LC-MS) method for the determination of etoposide levels in

human serum and plasma, Journal of chromatography B, Biomedical sciences

and applications. 744 (2000) 91-8.

[130] E.J. Eisenberg, W.M. Eickhoff, Determination of etoposide in blood by liquid

chromatography with electrochemical detection, Journal of Chromatography.

621 (1993) 110-4.

[131] G.F. Duncan, R.H. Farmen, H.S. Movahhed, K.A. Pittman, High-performance

liquid chromatographic method for the determination of etoposide in plasma

using electrochemical Detection, Journal of Chromatography. 380 (1985) 357-

65.

[132] P. Mandpe Leenata, Stress degradation studies on Iloperidone and

development of a stability indicating HPLC method for bulk drug and

pharmaceutical dosage form, Der Chemica Sinica. 2 (2011) 230.

[133] R. Venkata Mahesh, Development and validation of UV spectrophotometric

method for quantitative estimation of iloperidone in bulk and pharmaceutical

dosage form, Journal of Pharmacy Research. 5 (2012) 368.

[134] S. Manjula Devi et al, Validation of UV Spectrophotometric and HPLC

Methods for Quantitative determination fIloperidone in Pharmaceutical dosage

forms, International Journal of pharmtech Research. 4 (2012) 576-581.

[135] G. Saravanan, Mohammad, A validated reverse phase high performance liquid

chromatographic assay method for the estimation of iloperidone in bulk and

commercial tablet dosage form, Journal of Chemical and Pharmaceutical

Research. 5 (2013) 506-511.

157

[136] M. Naresh Chandra Reddy, estimation of 6-fluoro-3-(piperidin-4-yl) benzo [d]

isoxazole hydrochloride and 1-(4-(3-chloropropoxy)-3-methoxyphenyl)

ethanone of iloperidone in bulk and dosage form by RP HPLC, IJPBS.

2(2012) 208-217.

[137] M. Jia, Simultaneous determination of iloperidone and its two active

metabolites in human plasma by liquid chromatography-tandem mass

spectrometry application to a pharmacokinetic study, Journal of

Chromatography B. 928 (2013) 52-7.

[138] Huang Hong yong, Zhi Xiao yan, Wang Chuan sheng, Qian Dong li, Shi

Tian yuan, Determination of iloperidone in human plasma by RP-HPLC,

Zhongguo Xinyao Yu Linchuang Zazhi. 32 (2013) 731-734.

[139] Liu Ming zhou, Chen Ping, Li Jie, Wang Ru feng, Jia Fang, Ma Fang,

Zhang Xing chen, Hu Jun, Li Wei yong, Jia Meng meng, Determination of

iloperidone concentration in human plasma by HPLC-MS/MS, Zhongguo

Yiyuan Yaoxue Zazhi. 32 (2012) 1971-1974.

[140] M. Parekh Jignesh, Sanyal Mallika, Manish Yadav, Shrivastav, S. Pranav,

Stable-isotope dilution LC-MS/MS assay for determination of iloperidone and

its two major metabolites, P 88 and P95, in human plasm, application to a

bioequivalence study, Bioanalysis. 5 (2013) 669-86.

[141] Dhara patel, Development and validation of RP-HPLC method for

simultaneous estimation of risperidone and trihexyphenidyl hydrochloride in

tablet dosage forms, International Journal of Pharmaceutical Sciences review

and research. 4 (2010) 85-88.

[142] A.P. Suthar, Determination of Risperidone and forced degradation behavior by

HPLC in tablet dosage form, International Journal of Pharm Tech Research. 1

(2009) 568-574.

[143] S. Kulkarni, G. Chhabra, M. Shivani, Development and validation of UV

Spectrophotometric method for the determination of risperidone in bulk and

tablets formulation, International Journal of Pharmaceutical Chemistry. 1

(2012) 1-10.

[144] S. Dharmaraj Santhosam, An HPLC method for the simultaneous estimation

of risperidone and trihexyphenidyl hydrochloride from bulk and dosage forms,

HYGEIA Journal for Drugs and Medicines. 3 (2011) 29- 33.

158

[145] S.L. Baldania, EP HPLC estimation in tablet dosage forms, Indian journal of

pharmaceutical sciences, Indian Journal of Pharmaceutical Sciences. 702

(2008) 494-497.

[146] Ming zhu Huang, Determination of risperidone in human plasma by HPLC-

MS/MS and its application to a pharmacokinetic study in Chinese volunteers,

Journal of Zhejiang University Science B. 9 (2008) 114-120.

[147] R. Zarna, Stability Indicating HPLC Determination of Risperidone in Bulk

Drug and Pharmaceutical Formulations, International journal of analyticai

chemistry, Article Id 124917 (2011) 6.

[148] I. Akachukwu, N.J Nwodo, C.J Mbah, Spectrophotometric method for

determination of risperidone in pharmaceutical bulk and dosage forms,

International Journal of Pharmacy. 3 (2013) 710-715.

[149] Deepakumari, Hemavathi Nagaraju, Revanasiddappa, Hosakere

Doddarevanna, Use of the charge transfer reactions for the spectrophotometric

determination of risperidone in pure and in dosagE Forms, Journal of

Pharmaceutics. Article Id 792186 (2013) 6.

[150] Ashour Safwan, Kattan Nuha, Sensitive method for the quantitative

determination of risperidone in tablet dosage form by high-performance liquid

chromatography using chlordiazepoxide as internal standard, International

Journal of Biomedical Science. 9 (2013) 91-97.

[151] Sheeja Velayudhan Kutty, Yellinah Hari Babu, S. Greeshma, P.M. Vidhya,

Difference spectrophotometric method for the determination of Risperidone in

bulk and tablet dosage form, Pharma Innovation. 2 (2013) 44-49.

[152] S. Archana, Y. Naga Prasanna, P. Pavitra, D. Santhi Krupa, M. Hema Sri,

Development and validation of spectrophotometric method for determination

of risperidone by MBTH, International Journal of Pharmaceutical Sciences

and Research. 4 (2013) 1116-1119.

[153] B. Narayana, N. Shetty Divya, Development and validation of

spectrophotometric method for the determination of risperidone, Pharmacia

Lettre. 3 (2011) 104-109.

[154] Li Hongxia, Yang Dongjing, Fan Di, Wang Xueqin, Xing Xiangwei,

Determination of Risperidone and 9-hydroxyrisperidone in human plasma by

LC-MS/MS, Huaxi Yaoxue Zazhi. 26 (2011) 369-371.

159

[155] Chen Jianzheng, Liu Xiuying, Zheng Shijun, Content determination of

risperidone dispersible tablet by UV spectrophotometry, Zhongguo Yaofang.

22 (2011) 1906-1908.

[156] Hasan Moynul, Al Masud Abdullh, Ahmed Jamiuddin, Development and

validation of spectrophotometric method for the determination of Risperidone

in bulk drug andpharmaceutical formulation, International Journal of

Pharmaceutical Sciences and Research. 2 (2011) 378-382.

[157] S. Kathirvel Rao, G. Devala, S.V. Satyanarayana, UV spectrophotometric

determination of Risperidone in bulk and its formulation, Asian Journal of

Research in Chemistry. 3 (2010) 151-153.

[158] Duan Xiaotao, Chen Xiaoyan, Zhang Yifan, Zhong Dafang, Determination of

risperidone in human plasma by liquid chromatography tandem mass

spectrometry, Yaoxue Xuebao. 41 (2006) 684-688.

[159] Aravagiri Manickam, R. Marder Stephen, Simultaneous determination of

risperidone and 9-hydroxyrisperidone in plasma by liquid

chromatography/electrospray tandem mass spectrometry, Journal of Mass

Spectrometry. 35 (2000) 718-724.

[160] J.P. Le Moing, S. Edouard, J.C. Levron, Determination of risperidone and 9-

hydroxyrisperidone in human plasma by high-performance liquid

chromatography with electrochemical detection, Journal of Chromatography:

Biomedical Applications. 614 (1993) 333-9.

[161] Locatelli Igor, Mrhar Ales, Grabnar Iztok, Simultaneous determination of

risperidone and 9-hydroxyrisperidone enantiomers in human blood plasma by

liquid chromatography wit electrochemical detection, Journal of

pharmaceutical and biomedical analysis. 50 (2009) 905-10.

[162] Kousoulos Constantinos, Dotsikas Yannis, L. Loukas Yannis, Turbulent flow

and ternary column-switching on-line clean-up system for high-throughput

quantification of risperidone and its main metabolite in plasma by LC-

MS/MS: application to a bioequivalence study, Talanta. 72 (2007) 360-7.

[163] De Meulder Marc, M.M Remmerie Bart, De Vries Ronald, L.A. Sips Luc,

Boom Sandra, W.J Hooijschuur Edwin, C. Vande Merbel Nico, M.M.B.L

Timmerman Philip, Validated LC-MS/MS methods for the determination of

risperidone and the enantiomers of 9-hydroxyrisperidone in human plasma and

160

urine, Journal of chromatography B: Analytical technologies in the biomedical

and life sciences. 870 (2008) 8-16.

[164] B. Cabovska, S.L. Cox, A.A Vinks, Determination of risperidone and

enantiomers of 9-hydroxyrisperidone in plasma by LC-MS/MS, Journal of

chromatography B: Analytical technologies in the biomedical and life

sciences. 852 (2007) 497-504.

[165] Bhatt Jignesh, Subbaiah Gunta, Singh Sadhana, Liquid

chromatography/tandem mass spectrometry method for simultaneous

determination of risperidone and its active metabolite 9-hydroxyrisperidone in

human plasma, Rapid communications in mass spectrometry. 20 (2006) 2109-

14.

[166] Raggi Maria Augusta, Bugamelli Francesca, Sabbioni Cesare, Saracino Maria

Addolorata, Petio Carmine, HPLC-DAD determination of plasma levels of the

antipsychotic risperidone and its main metabolite for toxicological purposes, .

28 (2005) 245-50.

[167] E. Moody David, D. Laycock John, Huang Wei, L. Foltz Rodger, A high-

performance liquid chromatographic-atmospheric pressure chemical

ionization-tandem mass spectrometric method for determination of risperidone

and 9-hydroxyrisperidone in human plasma, Journal of analytical toxicology.

28 (2004) 494-7.

[168] B.M.M. Remmerie, L.L.A Sips, R. De Vries, J. De Jong, A.M. Schothuis,

E.W. Hooijschuur, N.C. van de Merbel, Validated method for the

determination of risperidone and 9-hydroxyrisperidone in human plasma by

liquid chromatography-tandem mass spectrometry, Journal of

chromatography. B, Analytical technologies in the biomedical and life

sciences. 783 (2003) 461-72.

[169] Jia Jingying, Zhang Mengqi, Lu Xiaopei, Lu Chuan, Li Shuijun, Liu Gangyi,

Yu Chen, Determination of risperidone and the enantiomer of 9-

hydroxyrisperidone in human plasma by LC-MS/MS, Zhongguo Linchuang

Yaoxue Zazhi. 19 (2010) 279-282.

[170] Gao Kepan, Chen Jun, Chen Qinghuav, Determination of risperidone and 9-

hydroxyrisperidone in rat plasma by LC-MS/MS, Zhongguo Yiyao Gongye

Zazhi. 41 (2010) 360-362.

161

[171] Mohammad Yunoos, B. Pragati Kumar, Subhani, Development and validated

new reverse phase HPLC method for the determination of risperidone in bulk

and tablet dosage forms, Research Journal of Pharmaceutical, Biological and

Chemical Sciences. 1 (2010), 165-171.

[172] Wen Yuguan, Liao Rifang, Zeng Zhuanping, Zhang Ming, Determination of

risperidone in plasma by LC-ESI-MS/MS, Guangdong Yaoxueyuan Xuebao.

23 (2007) 528-530.

[173] El Henawee, M. Magda, Spectrophotometric methods for the determination of

risperidone in pure and in dosage forms, Mansoura Journal of pharmaceutical

Sciences. 24 (2008) 43-51.

[174] Huang Zhuo, Sha Chun jie, Zhou Feng mei, Wan hui Liu, Yantai Daxue

Xuebao, Determination of risperidone and 9-hydroxyrisperidone in beagle

plasma by LC/MS, Ziran Kexue Yu Gongchengban. 21 (2008) 110-114.

[175] Seyyed Mohsen Foroutan, Afshin Zarghi, Alireza Shafaati, Arash Khoddam,

Rapid high performance liquid chromatographic determination of risperidone

in human plasma, Iranian Journal of Pharmaceutical Research. 5 (2006) 37-40.

[176] Li Zhang, Zheng Jiao, Zouqing Yao, Yan Zhong, Mingkang Zhong, Yunqiu

Yu, The validation of an LC-MS method for the determination of risperidone

and its active metabolite 9- hydroxyrisperidone in human plasma, Journal of

Chromatographia, 61 (2005) 245-251.

[177] Chongming Fu, Dengqin Wang, Ruichen Guo, Maoqin Tang, Simultaneous

determination of risperidone and 9-hydroxyrisperidone in human serum using

RP-HPLC and its clinical Application, Zhongguo Linchuang Yaolixue Zazhi.

17 (2001) 121-124.

[178] A. Avenoso, G. Facciola, M. Salemi, E. Spina, Determination of risperidone

and its major metabolite 9-hydroxyrisperidone in human plasma by reversed-

phase liquid chromatography with ultraviolet detection, Journal of

Chromatography B: Biomedical Sciences and Applications. 746 (2000) 173-

181.

[179] Hong Xiao, Jing Yang, Shining Zhang, Xinbao Zhang, Determination of

risperidone and 9-hydroxyrisperidone in plasma by high performance liquid

chromatography, Sepu. 17 (1999) 395-396.

162

[180] Robert Woestenborghs, Willy Lorreyne, Frank Van Rompaey, Jos Heykants,

Determination of risperidone and 9-hydroxyrisperidone in plasma, urine and

animal tissues by high-performanceliquid chromatography, Journal of

Chromatography, Biomedical Applications. 583 (1992) 223-30.

[181] A. El Sherif Zeinab, El Zeany Badr, M. El Houssini Ola, High performance

liquid chromatographic and thin layer densitometric methods for the

determination of risperidone inthe presence of its degradation products in bulk

powder and in tablets, Journal of pharmaceutical and biomedical analysis. 36

(2005) 975-81.

[182] Lerena Adrian, Berecz Roland, Dorado Pedro, de la Garza Cesar Sanz,

Norberto Maria Jesus, Caceres Macarena, Gutierrez Jose Ramon,

Determination of risperidone and 9-hydroxyrisperidone in human plasma by

liquid chromatography: application to theevaluation of CYP2D6 drug

interactions, Journal of chromatography B: Analytical technologies in the

biomedical and life sciences. 783 (2003) 213-9.

[183] T. Nagasaki, T. Ohkubo, K. Sugawara, N. Yasui, H. Furukori, S. Kaneko,

Determination of risperidone and 9-hydroxyrisperidone in human plasma by

high-performance liquid chromatography: application to therapeutic drug

monitoring in Japanese patients with schizophrenia, Journal of pharmaceutical

and biomedical analysis. 19 (1999) 595-601.

[184] O.V. Olesen, K. Linnet, Simplified high performance liquid chromatographic

method for determination of risperidone and 9-hydroxyrisperidone in serum

from patients comedicated with other psychotropic drugs, Journal of

chromatography B: Biomedical sciences and applications. 698 (1997) 209-16.

[185] Varanasi Murali Balaram, Mushraff Ali Khan, Validated reverse phase HPLC

method for the determination of topotecan in pharmaceutical dosage forms,

Oriental Journal of Chemistry. 25 (2009) 913-922.

[186] A. De Vries Nienke, Mariet Ouwehand, Tessa Buckle, H. Beijnen Jos, van

Tellingen, Olaf, Determination of topotecan in human and mouse plasma and

in mouse tissue homogenates by reversed-phase high-performance liquid

chromatography, Biomedical Chromatography. 21 (2007) 1191-1200.

[187] Walter J Loos, van Zomeren, M. Desiree, Hans Gelderblom, Jaap Verweij,

Kees Nooter, Gerrit Stoter, Alex Sparreboom, Determination of topotecan in

human whole blood and unwashed erythrocytes by high-performance liquid

163

chromatography, Journal of Chromatography B: Analytical Technologies in

the Biomedical and Life Sciences. 766 (2002) 99-105.

[188] M. Boucaud, F. Pinguet, S. Poujol, C. Astre, F. Bressolle, Sensitive high

performance liquid chromatographic fluorescence determination of topotecan

in human plasma and parotid saliva, Journal of Liquid Chromatography &

Related Technologies. 23 (2000) 2373-2390.

[189] W.J. Loos, G. Stoter, J. Verweij, J.H. Schellens, Sensitive high-performance

liquid chromatographic fluorescence assay for the quantitation of topotecan

(SKF 104864-A) and its lactone ring-opened product (hydroxy acid) in human

plasma and urine, Journal of chromatography B: Biomedical applications. 678

(1996) 309-15.

[190] M. Samya, El Gizawy, H. Osama Abdelmageed, A. Omar Mahmoud, M.

Deryea Sayed, M. Ahmed, Abdel Megied, Development and Validation of

HPLC Method for Simultaneous Determination of Amlodipine, Valsartan,

Hydrochlorothiazide in Dosage Form and Spiked Human Plasma, American

Journal of Analytical Chemistry. 3 (2012) 422-430.

[191] M. Farouk, Omar Abd Elaziz, M. Shereen Tawakkol, A. Hemadan, M.

Shehata, Liquid chromatography electro spray ionization tandem mass

spectrometry for simultaneous determination of amlodipine, benazepril and its

active metabolite benazeprilat in human plasma, Analytical Chemistry Letters.

4 (2014) 1-13.

[192] Lv Chan Mei, Chun Min, Fan Long Bu, Rui Chen, Wang Xiao Lu, Rong Li

Ben Jie Wang, Rui Chen Guo, Determination of amlodipine in human plasma

by LC-MS/MS and its bioequivalence study in healthy Chinese subjects,

Pharmacology & Pharmacy. 4 (2013) 191-200.

[193] Li na Zhang, Man Liu, Man Yang, Ali hua Du, Ya nan Zhang, Dan Zhang,

Jing Hang, Xiao lin Wang, Hui chen Lui, Determination of amlodipine

concentration in human plasma by LC-MS/MS method and bioequivalence

study of its tablets, ZhongguoYaofang. 24 (2013) 910-913.

[194] Yan Wang et al, LC-MS/MS determination of amlodipine in human plasma,

Zhipu Xuebao. 33 (2012) 181-185.

[195] Ying Zhou et al, Development and validation of a liquid chromatography

tandem mass spectrometry method for simultaneoud determination of

amlodipine, atovastatin and its metabolities ortho hydroxyl atovastatin and

164

para hydroxyl atovastatin in human plasma and its application in a

bioequivalence study, Journal of Pharmaceutical and Biomedical Analysis. 83

(2013) 101-107.

[196] Mahmoud Yacoub, Abu Awwad Ahmad, Alawi Mahmoud, Arafat Tawfiq,

Simultaneous determination of amlodipine and atorvastatin with its

metabolities, ortho and para hydroxyl atorvastatin in human plasma by LC-

MS/MS, Journal of Chromatography B: Analytical Technologies in the

Biomedical and Life Sciences. 1 (2013) 917-918, 36-47.

[197] Huichao Chang, Li Jinyin, Li Ji, Guan Xiaoduo, Sun Fanlu, Qian Zhongzhi, Bi

Kaishun, Fan Guorong, Simultaneous determination of amlodipine and

bisoprolol in rat plasma by a liquid chromatography/tandem mass

spectrometry method and its application in pharmacokinetic study, Journal of

Pharmaceutical and Biomedical Analysis 71 (2012) 104-110.

[198] Shentu Jianzhong, Fu Lizhi, Zhou Huili, Hu Xing Jiang, Liu Jian, Chen

Junchun, Wu Guolan, Determination of amlodipine in human plasma using

automated online solid phase extraction HPLC tandem mass spectrometry:

Application to a bioequivalence study of Chinese volunteers, Journal of

Pharmaceutical and Biomedical Analysis. 70 (2012) 614-618.

[199] Ta Manh Hung, Nguyen Thi Dung, Pham Thanh Huyen, Determination of

amlodipine in human plasma by chromatography-tandem mass spectrometry,

Tap Chi PhanTich Hoa Ly Va Sinh Hoc. 15 (2010) 8-12.

[200] Liu Wei, Zhang, Qing, Determination of amlodipine besylate and atorvastatin

calcium in human plasma by LC-MS/MS, Yiyao Daobao. 29 (2010) 698-701.

[201] Feng Shi yin, Xiang Jin, Qin Yong ping, Liang Mao zhi, Yu Qin, Nan Feng,

Determination of Amlodipine in human plasma with LC-MS/MS, Huaxi

Yaoxue Zazhi. 24 (2009) 512-514.

[202] Yue Jin, Zhao Xi, Zhang Yanling, He Yingna, Yang Hanyu, Determination of

amlodipine and atorvastatin in dog's plasma by LC-MS/MS, Zhongguo Yiyao

Gongye Zazhi. 40 (2009) 295-297.

[203] Zhang Zhi feng, Li Jing, Xiao Hong tao, Wu Chun lei, Determination of

amlodipine besylate in plasma and its pharmacokinetics by HPLC-MS-MS,

Xinan Minzu Daxue Xuebao, Ziran Kexueban. 35 (2009) 776-780.

165

[204] Zou, Qiaogen, Zhan Ying, Ge Zhengxiang, Wei Ping, Ouyang Pingkai, Liquid

chromatography-mass spectrometry method for the determination of

amlodipine in human plasma and its application in a bioequivalence study,

Arzneimittel Forschung. 59 (2009) 383-391.

[205] Thai Hong Hanh, Cao Thi Cam Tu, Tran Thi Quynh Chi, Nguyen Ngoc Vinh,

Nguyen Duc Tuan, Determination of amlodipine in human plasma by

LC/MS/MS methods, Tap Chi Duoc Hoc. 49 (2009) 25-28.

[206] Yao Wen, Wang Xiaobo, Xi Ronggang, Song Xiaonan, Liu Dan,

Determination of amlodipine in human plasma by LC/MS/MS: application to

bioequivalence and pharmacokinetics study, ZhongguoYiyuanYaoxue Zazhi.

28 (2008) 981-984.

[207] Zou, Jian jun, Zhu Yu bing, Yu Cui xia, Fan Hong wei, Xiao Da wei, Sheng

Hui, Wang Wen tao, Determination of amlodipine in human plasma by HPLC-

MS and study on its bioequivalence, Zhongguo Linchuang Yaoxue Zazhi. 16

(2007) 214-217.

[208] Liu Mei, Zhang Yan, Wen Ai dong, Yang Lin, Li Wei, Yuan Jing, Gao Xiao

hua, Determination of amlodipine in human plasma by LC-MS/MS method

and pharmacokinetics of amlodipine besylate tablets in healthy volunteers,

Zhongguo Linchuang Yaoxue Zazhi. 16 (2007) 211-214.

[209] Gu Hong an, Miao Ji kang, Zhang Shu hua, Liu Yun, Liu Gang yi, Lu Chuan,

Yu Chen, Determination of Amlodipine besylate in human serum by LC-

MS/MS method, Zhongguo Xinyao Yu Linchuang Zazhi. 26 (2007) 737-740.

[210] Zheng Feng, Wu Chun yong, Shao Lin zhi, Qian Xiao ping, Chen Lei, Liu

Wen ying, Gao Shu, Jiang Zhi wen, Determination of amlodipine in human

plasma by LC-ESI-MS/MS method, Zhongguo Yaoxue Zazhi. 41 (2006)

1663-1666.

[211] B. Streel, C. Laine, C. Zimmer, R. Sibenaler, A. Ceccato, Enantiomeric

determination of amlodipine in human plasma by liquid chromatography

coupled to tandem mass spectrometry, Journal of Biochemical and

Biophysical Methods. 54 (2002) 357-368.

[212] Chen Xiaoyan, Luan Yan, Zhong Dafang, Du Zongmin, Determination of

amlodipine in human plasma by liquid chromatography-tandem mass

spectrometry, Yaoxue Xuebao. 36 (2001) 51-54.

166

[213] Yasuda Taeko, Tanaka Mitsuko, Iba Kazuhiko, Quantitative determination of

amlodipine in serum by liquid chromatography with atmospheric pressure

chemical ionization tandem mass spectrometry, Journal of Mass Spectrometry.

31 (1996) 879-884.

[214] Pan Hua Ling, Lin Li Shan, Ding Jue Fang, Chen Xiao Yan, Zhong Da Fang,

Simultaneous determination of amlodipine, benazepril and benazeprilat in

human plasma by LC-HESI/MS/MS method, Acta Pharmaceutica Sinica. 49

(2014) 95-100.

[215] Feng Yan, Zhang Liang, Shen Zheng, Pan Fengyun, Zhang Zhengxing,

Analysis of amlodipine in human plasma by liquid chromatography-mass

spectrometry, Journal of chromatographic science. 40 (2002) 49-53.

[216] P.S. Jain, M.K. Patel, S.B. Bari, S.J. Surana, Development and validation of

HPTLC method for simultaneous determination of amlodipine besylate and

metoprolol succinate in bulk and tablets, Indian Journal of Pharmaceutical

Sciences. 74 (2012) 152-156.

[217] R. Ambadas Rote, K. Sadhana Kande, Development of HPTLC method for

determination of amlodipine besylate and olmesartan medoxomil using human

plasma by liquid liquid extraction, Journal of Analytical and Bioanalytical

Techniques. 2 (2011) 128.

[218] A.B. Thomas, S.N. Jagdale, R.K. Nanda, L.P. Kothapalli, A.D. Deshpande,

Stability indicating HPTLC method for the simultaneous determination of

amlodipine besylate and telmisartan from tablet dosage form, Journal of

Pharmaceutical Research. 10 (2011) 66-72.

[219] K.H. Gopani, S.S. Havele, S.R. Dhaneshwar, Application of high performance

thin layer chromatography densitometry for the simultaneous determination of

amlodipine besylate and lisinopril in bulk drug and tablet formulation,

International Journal of Pharmacy and Technology. 3 (2011) 2353-2367.

[220] Susheel John Varghese, Thengungal Kochupappy Ravi, Quantitative

simultaneous determination of amlodipine, valsartan, and hydrochlorothiazide

in Exforge HCT tablets using HPLC and high performance thin layer

chromatography, Journal of Liquid Chromatography & Related Technologies.

34 (2011) 981-994.

167

[221] Vandana B Patel, Rajnikanta Sahu, Bhumika M Patel, Simultaneous

determination of amlodipine besylate and atorvastatin calcium in

pharmaceutical tablet formulation by high performance thin layer

chromatographic method, International Journal of Chem Tech Research. 3

(2011) 695-698.

[222] K.R. Gupta, S.B. Wankhede, M.R. Tajne, S.G. Wadodkar, Simultaneous

determination of amlodipine and ramipril by high performance thin layer

chromatography, Asian Journal of Chemistry. 19 (2007) 4177-4182.

[223] S.N. Meyyanathan, B. Suresh, HPTLC Method for the Simultaneous

Determination of Amlodipine and Benazepril in Their Formulations, Journal

of Chromatographic Science. 43 (2005) 73-75.

[224] Kaliappan Ilango, Pabbisetty Bala Shanmuga Kumar, Karunanidhi Santhana

Lakshmi, Simple and rapid high-performance thin-layer chromatographic

determination of amlodipine and atenolol in pharmaceutical dosage forms,

Indian Drugs. 37 (2000) 497-499.

[225] K. Ilango, P.B. Kumar, V.R. Vijaya Prasad, Simple and rapid high-

performance thin layer chromatographic determination of amlodipine in

pharmaceutical dosage forms, Indian Journal of Pharmaceutical Sciences. 59

(1997) 336-337.

[226] P.S Jain, M.K. Patel, S.B. Bari, S.J. Surana, Development and Validation of

HPTLC Method for Simultaneous Determination of Amlodipine Besylate and,

Indian journal of pharmaceutical sciences, 74 (2012) 152-6.

[227] YarramRamakoti Reddy, Kakumani Kishore Kumar, M.R.P. Reddy, K.

Mukkanti, Rapid determination of amlodipine besylate and valsartan in

pharmaceutical preparations by stability-indicating ultra performance liquid

chromatography, Analytical Chemistry: An Indian Journal. 11 (2012) 335-

341.

[228] Bathula Shiva N.V. Prasad, Karuna Prasad Devani, Quantitative determination

of Amlodipine in human plasma by ultra performance liquid chromatography

electro spray ionization mass spectrometry: application to a clinical

pharmacokinetic study, Asian Journal of Pharmaceutical and Clinical

Research. 5 (2012) 89-93.

168

[229] Lu Dingqiang, Dang Anwang, Wang Jun, Ling Xiuquan, Li Yanliang, Jia Jing,

Tu Qingbo, NP HPLC separation and determination of amlodipine

enantiomers, Fenxi Ceshi Xuebao. 28 (2009) 1291-1294.

[230] M. Josefsson, B. Norlander, Coupled column chromatography on a Chiral-

AGP phase for determination of amlodipine enantiomers in human plasma: an

HPLC assay with electrochemical detection, Journal of Pharmaceutical and

Biomedical Analysis. 15 (1996) 267-277.

[231] Alnowaiser, Maha Abdalla, Simultaneous determination of amlodipine and

atorvastatin in Caduet tablets using HPLC, American Journal of Applied

Sciences. 10 (2013) 849-852.

[232] Gumustas Mehmet, A. Ozkan Sibel, A validated stability-indicating RP-LC

method for the simultaneous determination of amlodipine and perindopril in

tablet dosage form and their stress degradation behavior under ICH-

recommended stress conditions, Journal of AOAC International. 96 (2013)

751-757.

[233] L. Peikova, B. Tsvetkova, RP-HPLC method for simultaneous determination

of amlodipine besylate and valsartan in pharmaceutical dosage form,

Pharmacia. 60 (2013) 19-23.

[234] A. Hemke, M. Bhure, V. Anjankar, K. Gupta, Validated RP-HPLC method for

simultaneous determination of Amlodipine, Hydrochlorothiazide and

Valsartan in pharmaceutical formulation , International Journal of Pharmacy

and Technology. 5 (2013) 5383-5392.

[235] P. Pandya Gaurang, S. Hitendra Joshi, Development and validation of stability

indicating HPLC assay method for simultaneous determination of amlodipine

besylate, olmesartan medoxomil and hydrochlorothiazide in tablet

formulation, Pharmacia Sinica. 4 (2013) 145-152.

[236] Boyka G. Tsvetkova, Lily P. Peikova, Development and validation of RP-

HPLC method for simultaneous determination of Amlodipine Besylate and

Hydrochlorothiazide in pharmaceutical dosage form, Journal of Chemical and

Pharmaceutical Research. 5 (2013) 271-275.

[237] Jayesh G. Panchal, Ravindra V. Patel, Bhoomika R. Mistry, Shobhana K

Menon, Development and validation of reversed-phase LC method for

simultaneous determination telmisartan, amlodipine and their degradation

169

products in fixed dose combination tablets, Eurasian Journal of Analytical

Chemistry. 7 (2012) 28-42.

[238] Samia M. Gizawy, Loris I. Bebawy, Osama H. Abdelmageed, Mahmoud A.

Omar, Sayed M. Deryea, Abdel Megied, M. Ahmed, High performance liquid

chromatography, TLC-densitometry, and first derivative spectrophotometry

for simultaneous determination of amlodipine and perindopril in bulk powder

and its tablets, Journal of Liquid Chromatography & Related Technologies. 36

(2013) 1323-1339.

[239] D. Varma, P.S.R.C.H.N.P, A. Lakshmana Rao, S.C. Dinda, Validated stability

indicating HPLC method for simultaneous determination of amlodipine and

metoprolol in bulk drug and pharmaceutical formulations, International

Journal of Research in Pharmacy and Chemistry. 2 (2012) 876-884.

[240] W. Nouruddin Ali, S. Nada Abdelwahab, M. Marco Zaki, M. Abdelkawy,

Validated chromatographic methods for simultaneous determination of

Amlodipine besylate and Perindopril Arginine in binary mixtures and in

pharmaceutical dosage form, Journal of Chromatography and Separation

Techniques. 3 (2012) 134.

[241] M. Samya El Gizawy, H. Osama Abdelmageed, A. Mahmoud Omar, M. Sayed

Deryea, M. Ahmed Abdel Megied, Development and validation of HPLC

method for simultaneous determination of amlodipine, valsartan,

hydrochlorothiazide in dosage form and spiked human plasma, American

Journal of Analytical Chemistry. 3 (2012) 422-430.

[242] K. Anandakumar, D. Jothieswari, R. Subathrai, D.V. Santhi, T. Vetrichelvan,

Validated RP-HPLC method for the simultaneous determination of amlodipine

besylate, valsartan, and hydrochlorothiazide in bulk and in pharmaceutical

formulation, Acta Chromatographica. 24 (2012) 37-50.

[243] Hemandra Kumar Sharma, Vinod Sahu, Rahul Sahu, Neha Sengar, Sneha

Kulkerni, Development and validation of a RP-HPLC method for

simultaneous determination of amlodipine besylate and hydrochlorthiazide in

tablet dosage form, International Journal of Research in Pharmacy and

Science. 1 (2011) 66-74.

[244] R.A. Mhaske, D.J. Garole, A.A. Mhaske, S. Sahasrabudhe, RP-HPLC method

for simultaneous determination of Amlodipine Besylate, Valsartan,

170

Telmisartan, Hydrochlorothiazide and Chlorthalidone: application to

commercially available drug products, International Journal of Pharmaceutical

Sciences and Research. 3 (2012) 141-149.

[245] T. Deepan, V. Alekhya, V. Sekar, P. Perumal, M.D. Dhanaraju, High

performance liquid chromatographic method for determination of Amlodipine

besilate and Olmesartan medoxomil in tablet dosage form, International

Journal of Chemical and Pharmaceutical Sciences. 2 (2011) 5-8.

[246] D. Jothieswari, K. Anandakumar, D. Vijaya Santhi, B. Vijayakumar, D. Priya,

B. Stephen Rathinaraj, Validated RP HPLC method for the simultaneous

determination of amlodipine besylate, valsartan and hydrochlorothiazide in

bulk and in pharmaceutical formulation, Journal of Pharmaceutical and

Biomedical Sciences. 4 (2011) 12.

[247] E. Vignaduzzo Silvana, M. Castellano Patricia, S. Kaufman Teodoro,

Development and validation of an HPLC method for the simultaneous

determination of amlodipine, hydrochlorothiazide, and valsartan in tablets of

their novel triple combination and binary pharmaceutical associations, Journal

of Liquid Chromatography & Related Technologies. 34 (2011) 2383-2395.

[248] Bhatia Neela Manish, Deshmane Snehal Jawaharlal, More Harinath Nivrutti,

Choudhari Praffula Balkrishna, Validated RP HPLC method for simultaneous

determination of amlodipine besylate and hydrochlorothiazide from

pharmaceutical preparation and biological samples, Research Journal of

Pharmacy and Technology. 2 (2009) 482-486.

[249] Ashpak Mubarak Tamboli, Naziya Iqbal Khan, Javed Yakub Manure, Sohrab

Akhtar Shaikh, Shrinivas Krishna Mohite, Development and validation of

stability indicating HPLC method for simultaneous determination of

amlodipine besylate and enalapril maleate, International Research Journal of

Pharmacy. 2 (2011) 185-191.

[250] S.M. Eyad Abu Nameh, Khalid Abu Shandi, Munib Saket, Maher Salim, O.M.

Othman, Y. Mohammad, Simultaneous determination of amlodipine besylate

and Valsartan in tablets by high performance liquid chromatography with UV

detection, Jordan Journal of Pharmaceutical Sciences. 4 (2011) 105-113.

171

[251] Dalong Yang, Yimei Ding, Dingqiang Lu, Determination of amlodipine

besylate and valsartan in compound valsartan tablets by HPLC, Zhongguo

Yiyao Gongye Zazhi. 42 (2011) 292-294.

[252] H. Nora Al Shaalan, A. Maha Alnowaiser, Simultaneous determination of

amlodipine besilate and valsartan in pharmaceutical formulation using high

performance liquid chromatography, Journal of Chemical and Pharmaceutical

Research. 2 (2010) 129-134.

[253] A.M. Tamboli, Chetan Chavan, S.K. Mohite, Development and validation of

a RP-HPLC method for simultaneous determination of amlodipine besylate

and enalapril maleate, Journal of Pharmacy Research. 3 (2010) 2564-2567.

[254] Dilek Kul, Burcu Dogan Topal, Tugba Kutucu, Bengi Uslu, A. Sibel Ozkan,

High-performance liquid chromatographic and first derivative of the ratio

spectrophotometric determination of amlodipine and valsartan in their binary

mixtures, Journal of AOAC International. 93 (2010) 882-890.

[255] K.R. Patil, V.P. Rane, J.N. Sangshetti, R.D. Yeole, D.B. Shinde, Stability

Indicating LC Method For the Simultaneous Determination of Amlodipine and

Olmesartan in Dosage Form, Journal of Chromatographic Science. 48 (2010)

601-606.

[256] Nilesh Jain, Ruchi Jain, Jitendra Banweer, Deepak Kumar Jain, Development

and validation of a rapid RP-HPLC method for the determination of

amlodipine besylate and olmesartan medoxomil in their combined tablet

formulation, International Journal of Current Pharmaceutical Research. 2

(2010) 40-43.

[257] B. Gajanan Kasawar, N. Mazahar Farooqui, Simultaneous determination of

amlodipine besylate and benazepril hydrochloride in pharmaceutical dosage

form by LC, Analytical Sciences. 25 (2009) 1495-1498.

[258] K. Raghu Naidu, N. Udhav Kale, S. Murlidhar Shingare, Stability indicating

RP-HPLC method for simultaneous determination of amlodipine and

benazepril hydrochloride from their combination drug product, Journal of

Pharmaceutical and Biomedical Analysis. 39 (2005) 147-155.

[259] J.R. Rao, S.S. Kadam, K.R Mahadik, Reverse phase high performance liquid

chromatographic determination of amlodipine and benazepril HCL in tablets,

Indian Drugs. 39 (2002) 378-381.

172

[260] U.P. Halkar, N.P. Bhandari, S.H. Rane, High performance liquid

chromatographic simultaneous determination of amlodipine and enalapril

maleate, from pharmaceutical preparation, Indian Drugs. 35 (1998) 168-169.

[261] S.S. Zarapkar, S.S Kolte, S.H. Rane, High-performance liquid

chromatographic determination of amlodipine and atenolol, simultaneously,

from pharmaceutical preparationS, Indian Drugs. 34 (1997) 350-353.

[262] A. Moussa Bahia, A. El Zaher Asmaa, A. Mahrouse Marianne, S. Ahmed

Maha, Simultaneous determination of amlodipine besylate and atorvastatin

calcium in binary mixture by spectrofluorimetry and HPLC coupled with

fluorescence detection, Analytical chemistry insights. (2013) 8107-15.

[263] Gumustas Mehmet, A. Ozkan Sibel, A validated stability-indicating RP-LC

method for the simultaneous determination of amlodipine and perindopril in

tablet dosage form and their stress degradation behavior under ICH-

recommended stress conditions, Journal of AOAC International. 96 (2013)

751-7.

[264] Ozdemir Filiz Arioz, Akyuz Atalay, Simultaneous Determination of

Amlodipine and Aliskren in Tablets by High-Performance Liquid

Chromatography, Journal of chromatographic science. 7 (2013)

DOI: 10.1093/chromsci/bmt099

[265] Deepak Sharma, Anurekha Jain, Alankar Shrivastava, Simultaneous

estimation of amlodipine besylate and nebivolol hydrochloride in tablet

dosage forms by reverse phase-high-performance liquid chromatographic

using ultraviolet detection, Pharmaceutical methods. 2 (2011) 9-14.

[266] B. Patel Deval, A. Mehta Falgun, K. Bhatt Kashyap, Simultaneous Estimation

of Amlodipine Besylate and Indapamide in a Pharmaceutical Formulation by a

High Performance Liquid Chromatographic (RP-HPLC) Method,

Scientiapharmaceutica. 80 (2012) 581-90.

[267] Hassan Heidari, Habib Razmi, Abolghasem Jouyban, Hplc determination of

amlodipine in biological fliuids using hollow fiber based liquid- liquid-liquid

microextraction, Journal of Liquid Chromatography & Related Technologies.

35 (2012) 963-976.

[268] D. Helen Leite, R.M. Maria Ines Santoro,M.A. Joao Porto, Pedro Lopez

Garcia, M. Mariana de Almeida,F. Vanessa Tavares, Kedor Hackmann, R.M.

173

Erika, Quantitative determination of amlodipine besylate in tablets by high

performance liquid chromatography and UV spectrophotometry, Latin

American Journal of Pharmacy. 30 (2011) 527-533.

[269] Yu Dong, Xiaoping Qian, Jingjing Sun, Determination of amlodipine besylate

tablets related substances by HPLC, ZhongguoYaopinBiaozhun, 11 (2010)

213-214.

[270] Amrish Sharma, Mukul Tailang, Bhaskar Gupta, Ashish Acharya, RP HPLC

determination of amlodipine in its pharmaceutical dosage forms, Asian Journal

of Research in Chemistry. 3 (2010) 129-131.

[271] A. Ibrahim Alsarra, High performance liquid chromatographic method for

quantitative determination of amlodipine in human plasma and pharmaceutical

dosage form and its application to pharmacokinetic studies, Journal of

Chromatographic Science. 47 (2009) 863-867.

[272] Guojin Xu, Xinchun Li, Determination of amlodipine bensylate and its related

substances by RP-HPLC with ultraviolet detection, Zhongguo Yaoxue Zazhi,

43 (2008) 60-63.

[273] Chengping Li, Xiaoping Yan, Weiguang Shan, HPLC determination of

amlodipine besylate tablets, Yaowu Fenxi Zazhi. 26 (2006) 1878-1879.

[274] F. Gedil Ustun, O. Atay, Quantitative determination of amlodipine containing

pharmaceuticals by IR spectroscopy and HPLC methods, Journal of Faculty of

Pharmacy of Istanbul University. 38 (2006) 37-46.

[275] A. Zarghi, S.M. Foroutan, A. Shafaati, A. Khoddam, Validated HPLC method

for determination of amlodipine in human plasma and its application to

pharmacokinetic studies, Farmaco. 60 (2005) 789-792.

[276] Kanakapura Basavaiah, Umakanthappa Chandrashekar, Paregowda

Nagegowda, Spectrophotometric and high performance liquid

chromatographic determination of amlodipine besylate in pharmaceuticals,

Science Asia. 31 (2005) 13-21.

[277] Yongjiang Wu, Yunxue Pan, Su Zeng, Determination of amlodipine in

CYP3A4 cDNA-expressed cells by HPLC, Zhejiang DaxueXuebao, Yixueban.

32 (2003) 510-513.

[278] Gh Bahrami, Sh Mirzaeei, Simple and rapid HPLC method for determination

of amlodipine in human serum with fluorescence detection and its use in

174

pharmacokinetic studies, Journal of Pharmaceutical and Biomedical Analysis.

36 (2004) 163-168.

[279] R. Klinkenberg, B. Streel, A. Ceccato, Development and validation of a liquid

chromatographic method for the determination of amlodipine residues on

manufacturing equipment surfaces, Journal of Pharmaceutical and Biomedical

Analysis. 32 (2003) 345-352.

[280] S. Tatar, S. Atmaca, Determination of amlodipine in human plasma by high-

performance liquid chromatography with fluorescence detection, Journal of

Chromatography B: Biomedical Sciences and Applications. 758 (2001) 305-

310.

[281] Fei Shang, Kuihong Shang, Determination of amlodipine in tablets by HPLC,

Zhongguo Yiyao Gongye Zazhi. 27 (1996) 411-413.

[282] A.B. Avadhanulu, J.S. Srinivas, Y. Anjaneyulu, Reverse phase HPLC

determination of Amlodipine besylate in drug and its pharmaceutical dosage

forms, Indian Drugs. 33 (1996) 36-40.

[283] A. Alsarra Ibrahim, High-performance liquid chromatographic method for

quantitative determination of amlodipine in human plasma and pharmaceutical

dosage form and its application to pharmacokinetic studies, Journal of

chromatographic science. 47 (2009) 863-7.

[284] Malesuik Marcelo Donadel, Cardoso Simone Goncalves, Bajerski Lisiane,

Lanzanova Fibele Analine, Determination of amlodipine in pharmaceutical

dosage forms by liquid chromatography and ultraviolet spectrophotometry,

International Journal of AOAC. 89 (2006) 359-64.

[285] Varaprasad Bobbarala, Somasekhar Penumajji, K. Useni Reddy Mallu,

Hussain Reddy, HPLC Method Development for Glucosamine Sulphate and

Diacerein Formulation, Journal of Pharmacy Research, Journal of Pharmacy

Research. 3 (2010) 361-363.

[286] A. Praneeth Kumar, P. Sunil Kumar Chaitanya, G. Rohini Reddy, S.K.

Umadevi, Method development & validation for simultaneous estimation of

diacerin and glucosamine sulphate by RP HPLC in bulk and tablet dosage

form, IAJPR. 4 (2014) 1369-1377.

[287] N. Kannappan, A.R. Madhukar, R.L.A. Srinivasan, Ch. Naveen kumar,

Mannavalan, analytical method development and validation of diacerein

175

tablets byRP-HPLC, International Journal of Chemical Technology Research.

2 (2010) 143-148.

[288] Purnima Hamrapurkar, Priti Patil, Sandeep Pawar, Stress degradation studies

and development of a validated stability-indicating-assay-method for

determination of diacerein in presence of degradation products,

Pharmaceutical methods. 2 (2011) 30-35.

[289] Thamma Narendra kumar, R. Sreenivasulu Raju, satya1, Useni Reddy Mallu,

A novel RP-HPLC method for the quantification of impurities in

glucosamine hydrochloride, International Journal of Research and Reviews in

Ppharmacy and Applied sciences. 2 (2011) 47-61.

[290] G. Ravindra babu, K.P.R. Chowdary, P. Sambasiva Rao, T.K. Preveen, V.

Ramanarayana Reddy, M. Chandrashekhar, Method development and

validation of simultaneous estimation of diacerien and aceclofenac of bulk and

pharmaceutical dosage by using rp-hplc, International Journal of Advances in

Pharmaceutical Research. 7 (2012) 996–1003.

[291] S. Patel, N.J. Patel, Simultaneous RP-HPLC and HPTLC estimation of

fluoxetine hydrochloride and olanzapine in tablet dosage forms, Indian Journal

of Pharmaceutical Sciences. 71 (2009) 477-80.

[292] B. Venkateswara Reddy, K.V.N. Suresh Reddy, J. Sreeramulu, G.V.

Kanumula, Simultaneous Determination of Olanzapine and Fluoxetine by

HPLC, Chromatographia. 66 (2007) 111-114.

[293] Pathak, S.J. Rajput, Development of a Stability-Indicating HPLC Method for

Simultaneous Determination of Olanzapine and Fluoxetine in Combined

Dosage Forms, Journal of Chromatographic Science. 47 (2009) 97-99.

[294] Charmy Shah, R. Shah, J. Nehal, Suhagi, Simultaneous Assay of Olanzapine

and Fluoxetine in Tablets by Column High-Performance Liquid

Chromatography and High-Performance Thin-Layer Chromatography, Journal

of AOAC International. 6 (2006) 204-209.

[295] A. Tantawy Mahmoud, Y. Hassan Nagiba, A. Elragehy Nariman, Mohamed

Abdelkawy, Simultaneous determination of olanzapine and fluoxetine

hydrochloride in capsules by spectrophotometry, TLC-spectrodensitometry

and HPLC, Journal of Advanced Research. 2 (2013) 173–180.

[296] S.L. Bonde, R.P. Bhadane, G.A. Avinash, S.R. Ikwad, D.U. Katale Gavali,

A.S. Narendiran, Simultaneous determination of Olanzapine and Fluoxetine

176

in human plasma by LC–MS/MS: Its pharmacokinetic application, Journal of

Pharmaceutical and Biomedical Analysis. 90 (2014) 564–71.

[297] Walter Sneader, Drug discovery: A History, Wiley, New York, 2005.

[298] O. Tournilhac, B. Cazin, S. Lepretre, M. Divine, K. Maloum, A. Delmer, B.

Grosbois, P. Feugier, F. Maloisel, F. Villard, B. Villemagne, D. Bastit, K.

Belhadj, N. Azar, M. Michallet, G. Manhes, P. Travade, Impact of frontline

fludarabine and cyclophosphamide combined treatment on peripheral blood

stem cell mobilization in B-cell chronic lymphocytic leukemia, Blood. 103

(2004) 363-5.

[299] H. Gonzalez, V. Leblond, N. Azar, L. Sutton, J. Gabarre, J.L. BinetL, J.P.

Vernant, G. Dighiero, Severe autoimmune hemolytic anemia in eight patients

treated with fludarabine, Hematol Cell Therapy. 40 (1998) 113-8.

[300] Basile, The Role of Existing and Newer Calcium Channel Blockers in the

Treatment of Hypertension, The Journal of Clinical Hypertension. 6 (2004)

621–29.

[301] Ehud Grossman, H. Franz Messerli, Calcium antagonists, Progress in

Cardiovascular Diseases. 47 (2004) 34–57.

[302] A. Claas Steven, P. Stephen Glasser, Long-acting diltiazem HCL for the

chronotherapeutic treatment of hypertension and chronic stable angina

pectoris, Expert Opinion on Pharmacotherapy. 6 (2004) 765–76.

[303] Full list of impurities found in cocaine, BBC, May 12, 2009.

[304] K.R. Hande, Etoposide: four decades of development of a topoisomerase II

inhibitor, Europian Journal of Cancer. 34 (1998) 1514–21.

[305] M. Kuhn, A. Von Wartbung, Podophyllum- Lignane: Structure and Absolute

configuration on Podorhizol-β-D-glucosid (Lignan F). 19. Mitt.

Übermitosehemmende Naturstoffe, Helvetica Chimica Acta. 50 (1967) 1546–

65.

[306] J.L. Longe Gale, Encyclopedia of Cancer: A Guide to Cancer and Its

Treatments, Detroit Thomson Gale. 2002, Pp. 397–399.

ISBN 978-1-4144-0362-5.

[307] Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug

Application, Vanda Pharmaceuticals, 11 (2007) 27.

177

[308] FDA Issues Not Approvable Letter for Iloperidone to Vanda Pharmaceuticals,

Vanda Pharmaceuticals.7 (2008) 28.

[309] Vandas Schizophrenia Drug Wins Approval from U.S. Regulators,

Bloomberg. 5 (2009).

[310] L. Scott, Iloperidone in Schizopherenia, CNS Drugs. 23(2009) 867-880.

[311] L.L. Brunton, Goodman, Gilman, The Pharmacological Basis of Therapeutics,

Twelth Edition., McGraw Hill Medical publishing division, New Delhi, 2010.

[312] A.M. Barr, S.B. Powell, A. Markou, M.A. Geyer, Iloperidone reduces

sensorimotor gating deficits in pharmacological models, but not a

developmental model, of disrupted prepulse inhibition in rats,

Neuropharmacology. 51 (2006) 457–65.

[313] M.R. Szewczak, R. Corbett, D.K. Rush, C.A. Wilmot, P.G. Conway, J.T.

Strupczewski, M. Cornfeldt, The pharmacological profile of iloperidone, a

novel atypical antipsychotic agent, The Journal of Pharmacology and

Experimental Therapeutics. 274 (1995) 1404–13.

[314] Truven health analytics, Inc. Drug point System, Cited 2013 sep 18.

[315] K. Komossa, C. Rummel Kluge, S. Schwarz, F. Schmid, H. Hunger, W.

Kissling, S. Leucht,Risperidone versus other atypical antipsychotics for

schizopherenia, The Cochrane database of systematic reviews (1): CD006626.

Doi: 10.1002/14651858.CD006626.pub2.

[316] WHO Model List of Essential Medicines, World Health Organization. October

2013. Retrived 22 April 2014.

[317] Risperdal at naminh.org/resources.

[318] Respiridone, The American Society of Health system Pharmacists, 2011.

[319] R.D. Rattehalli, M.B. Jayaram, M. Smith, Ranganath, ed. Cochrane Database

System revision (1): CD006918, 2010.

[320] A.R. Maher, G. Theodore, Summary of the comparative effectiveness review

in off- label use of atypical antipsychotics. J Manag Care Pharm. 18 (2012) 20.

[321] Risperdal Prescribing Information Label, Drugs@FDA: FDA Approved Drug

Products, Jannsen Pharmaceuticals, Inc, 2014.

[322] L. Brunton, B. Chabner, B. Knollman, Goodman, Gilman,The

Pharmacological Basis of Therapeutics, Twelfth Edition, McGraw Hill

Professional, 2010.

178

[323] R.M. Abou El Magd, H.K. Park, T. Kawazoe, S. Iwana, K. Ono, S.P. Chung,

M. Miyano, K. Yorita, T. Sakai, K. Fukui, The effect of risperidone on D-

amino acid oxidase activity as a hypothesis for a novel mechanism of action in

the treatment of schizophrenia, Journal of Psychopharmacology. 24 (2010) 23.

[324] E.M. Hecht, D.C. Landy, Alpha-2 receptor antagonist add-on therapy in the

treatment of schizophrenia; a meta-analysis, Schizophrenia Research. 134

(2013) 202–6.

[325] Risperidone PubMed Health. Ncbi.nlm.nih.gov, 2012.

[326] FDA Rubber Stamps APP Pharmas Generic Topotecan for Small Cell Lung

and Cervical Cancers, 30 Nov 2010.

[327] DNA Topoisomerases and Cancer, Yves Pommier Editor, Humana Press,

2012.

[328] F. Schmidt, J. Rieger, J. Wischhusen, U. Naumann, M. Weller, cell sensitivity

to topotecan: the role of p53 and topotecan-induced DNA damage, Europian

Journal of Pharmacology. 412 (2001) 21-5.

[329] S.A. Streltsov, A.L. Mikheikin, Interaction of topotecan—a DNA

topoisomerase I inhibitor—with dual-stranded polydeoxyribonucleotides. II.

Formation of a complex containing several DNA molecules in the presence of

topotecan, Mol Biol. 35 (2001) 442-50.

[330] S.A. Streltsov, Action models for the antitumor drug camptothecin: formation

of alkali-labile complex with DNA and inhibition of human DNA

topoisomerase I, Journal of Biomolecule Structure Dyn. 20 (2000) 447-54.

[331] WHO Model List of EssentialMedicines. World Health Organization. October

2013, Retrieved 22, April 2014.

[332] Amlodipine Besylate. The American Society of Health-System Pharmacists.

Retrieved 3 April 2011.

[333] J.G. Wang, Vascular health and risk management. 5 (2009) 593–605.

[334] WWW.Sandoz product information sheet.

[335] Harry Gouvas, Use of Sodium Hyaluronate in the treatment of Osteoarthritis,

Greece, 2011.

[336] T.S. Fidelix, B.G. Soares, V.F. Trevisani, Diacerein for osteoarthritis,

Cochrane database of systematic reviews (Online), 1, 2006.

179

[337] J.P. Pelletier, Efficacy and safety of diacerein in osteoarthritis of the knee: a

double-blind, placebo-controlled trial. The Diacerein Study Group, Arthritis

Rheumatology. 43 (2000) 2339-48.

[338] Georg Ledderhose, Uber salzsaures Glycosamine, Berichte der deutschen

chemischen Gesellschaft. 9 (1876) 1200–1201.

[339] G. Ledderhose, Uber Chitin und seine Spaltungs produkte, Zeitschrift fur

physiologische Chemie, 2 (1878) 213–227.

[340] G. Ledderhose, Uber Chitin und seine Spaltungs produkte, Uber Glykosamin

Zeitschrift fur physiologische Chemie. 2 (1880) 139–159.

[341] W.W. Pigman, D. Horton, J.D. Wander, The Carbohydrates, Academic Press,

Vol IB, New York, 1980, Pp. 727–728.

[342] W.N. Haworth, W.H.G. Lake, S.Peat, The configuration of glucosamine

(chitosamine), Journal of the Chemical Society. (1939) 271–274.

[343] Gary Mc Farlane, Journal of osteoarthritis and fibromyalgia. ARC (2010) 44–

46.

[344] M. Lafontaine Lacasse, M. Dore, F. Picard, Hexosamines stimulate apoptosis

by altering Sirt1 action and levelsin rodent pancreatic β-cells, Journal of

Endocrinology. 208 (2011) 41–9.

[345] S. Leucht, A. Cipriani, L. Spineli, Comparative efficacy and tolerability of 15

antipsychotic drugs in schizophrenia: a multiple treatments meta analysis,

Lancet. 382 (2013) 951–62.

[346] D.N. Osser, M.J. Roudsari, T. Manschreck, The psychopharmacology

algorithm project at the Harvard South Shore Program: an update on

schizophrenia, Harv Rev Psychiatry. 21 (2013) 18–40.

[347] J.P. Zhang, J.A. Gallego, D.G. Robinson, A.K. Malhotra, J.M. Kane, C.U.

Correll, Efficacy and safety of individual second-generation vs first-generation

antipsychotics in first-episode psychosis: a systematic review and meta-

analysis, International Journal of Neuropsychopharmacology. 16 (2013) 1205–

18.

[348] L. Citrome, A systematic review of meta-analyses of the efficacy of oral

atypical antipsychotics for the treatment of adult patients with schizophrenia,

Expert Opin Pharmacother. 13 (2012) 1545–73.

180

[349] P. Lepping, R.S. Sambhi, R. Whittington, S. Lane, R. Poole, Clinical

relevance of findings in trials of antipsychotics: systematic review, British

Journal of Psychiatry. 198 (2011) 341–5.

[350] S. Leucht, A. Cipriani, L. Spineli, D. Mavridis, D. Orey, F. Richter,

Comparative efficacy and tolerability of 15 antipsychotic drugs in

schizophrenia: a multiple-treatments meta-analysis, The Lancet. 382 (2013)

951–62.

[351] C. Stollberger, W. Lutz, J. Finsterer, Heat-related side-effects of neurological

and non-neurological medication may increase heatwave fatalities, European

Journal of Neurology. 16 (2009) 879–882.

[352] OLANZAPINE tablet, orally disintegrating, DailyMed. Prasco Laboratories.

September 2013. Retrieved 26 November 2013.

[353] Olanzapine 10 mg tablets - Summary of Product Characteristics, electronic

Medicines Compendium. Aurobindo Pharma - Milpharm Ltd, 2013.

[354] T. Wong David, S. Horng Jong, P. Bymaster Frank, L. Hauser Kenneth,

Molloy, B. Bryan, A selective inhibitor of serotonin uptake: Lilly 110140, 3-

(p-Trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine, Life Sciences.

15 (1974) 471–9.

[355] Randi Jenssen Hagerman, Dech, Budow, Anecdotal use of fluoxetine in a case

of PWS to control behavior problems, appetite, and trichotillomania,

Neurodevelopmental Disorders: Diagnosis and Trea.tment. Oxford University

Press. 1999.

[356] K. Williams, Selective serotonin reuptake inhibitors for autism spectrum

disorders, Cochrane Database Systematic Review, 8, 2010.

[357] S.M. Myers, The status of pharmacotherapy for autism spectrum disorders,

Expert Opinion on Pharmacotherapy. 8 (2007) 1579–1603.

[358] C.A. Doyle, C.J. Mc Dougle, Pharmacotherapy to control behavioral

symptoms in children with autism, Expert Opinion on Pharmacotherapy. 13

(2012) 1615–1629.

[359] A. Benvenuto, B. Battan, M.C. Porfirio, P. Curatolo, Pharmacotherapy of

autism spectrum disorders, Brain and Development. 35 (2013) 119–127.

[360] A. Brayfield., Fluoxetine Hydrochloride-Martindale: The Complete Drug

Reference, Pharmaceutical Press, London, 2013.

181

[361] R.D. Bland, T.L. Clarke, L.B. Harden, Rapid infusion of sodium bicarbonate

and albumin into high-risk premature infants soon after birth: a controlled,

prospective trial, American Journal of Obstet Gynecology. 124 (1976) 263–7.

[362] M.A. Koda Kimble., B.K. Alldredge, Applied therapeutics: the clinical use of

drugs, tenth ed., Baltimore: Wolters Kluwer Health/Lippincott Williams &

Wilkins, 2012.